Busulfan Injection
- Product: Generic
- Presentation: Lyophilized Powder for Injection (IV)
- Strengths: 2 mg & 3.5 mg per vial
We are a reputable distributor and exporter of Busulfan Injection, an alkylating medication broadly applied to treat chronic myeloid leukemia (CML) and as conditioning therapy before hematopoietic stem cell transplantation (HSCT). It is available in vials of 2 mg and 3.5 mg with bulk pack, OEM/private labeling, and export documentation.
Description
By cross-linking DNA, busulfan, a potent alkylating antineoplastic, stops cancer cells from growing. It has a significant impact on:
- Chronic Myeloid Leukemia (CML) treatment
- Conditioning regimens before bone marrow or stem cell transplantation
Under close medical supervision, busulfan is given intravenously (IV).
We supply to oncology hospitals, government tenders, cancer centers, and international distributors across Asia, Africa, LATAM, and Middle East.
Q1. That is, what are Busulfan Injection indications?
A: Busulfan is indicated for conditioning before stem cell transplant and chronic myeloid leukemia (CML) treatment.
Q2. What benefits do we offer?
A: We provide 2 mg and 3.5 mg vials, available in bulk pack to global wholesalers. That is,
Q3. In what manner is it administered?
A: Busulfan is administered intravenously under the medical expertise of a qualified professional.
Q4. Do you offer OEM or private labeling?
A: Yes, OEM/private labeling and neutral packaging available for export and wholesale customers.
Q5. Are your products export certified?
A: Yes, from WHO-GMP/ISO approved facilities, with complete export compliance.
You may also be interested in Azithromycin Tablets– a powerful option for resistant infections.
